These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 16391393)

  • 1. Facing the enigma of immunomodulatory effects of intravenous immunoglobulin.
    Sapir T; Shoenfeld Y
    Clin Rev Allergy Immunol; 2005 Dec; 29(3):185-99. PubMed ID: 16391393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunomodulatory effects of intravenous immunoglobulins as a treatment for autoimmune diseases, cancer, and recurrent pregnancy loss.
    Sapir T; Blank M; Shoenfeld Y
    Ann N Y Acad Sci; 2005 Jun; 1051():743-78. PubMed ID: 16127014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of action of intravenous immune globulin in immune-mediated diseases.
    Mouthon L; Kaveri SV; Spalter SH; Lacroix-Desmazes S; Lefranc C; Desai R; Kazatchkine MD
    Clin Exp Immunol; 1996 May; 104 Suppl 1():3-9. PubMed ID: 8625540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mechanisms of action of intravenous immunoglobulins in the treatment of autoimmune diseases].
    Mouthon L; Hurez V; Kazatchkine M
    Ann Med Interne (Paris); 1993; 144(8):506-13. PubMed ID: 8179238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uncovering the hidden potential of intravenous immunoglobulin as an anticancer therapy.
    Sapir T; Shoenfeld Y
    Clin Rev Allergy Immunol; 2005 Dec; 29(3):307-10. PubMed ID: 16391406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IVIG--mechanisms of action.
    Simon HU; Späth PJ
    Allergy; 2003 Jul; 58(7):543-52. PubMed ID: 12823109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of natural antibodies in immune homeostasis: IVIg perspective.
    Vani J; Elluru S; Negi VS; Lacroix-Desmazes S; Kazatchkine MD; Bayry J; Kaveri SV
    Autoimmun Rev; 2008 Jun; 7(6):440-4. PubMed ID: 18558359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune modulating effects of intravenous immunoglobulin (IVIg) in autoimmune diseases.
    Mouthon L; Kaveri S; Kazatchkine M
    Transfus Sci; 1994 Dec; 15(4):393-408. PubMed ID: 10155557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of action of intravenous immunoglobulin in autoimmune and inflammatory diseases.
    Bayry J; Misra N; Latry V; Prost F; Delignat S; Lacroix-Desmazes S; Kazatchkine MD; Kaveri SV
    Transfus Clin Biol; 2003 Jun; 10(3):165-9. PubMed ID: 12798851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel cross-reactive anti-idiotype antibodies with properties close to the human intravenous immunoglobulin (IVIg).
    Macias A; Arce S; Leon J; Mustelier G; Bombino G; Domarco A; Perez R; Lage A
    Hybridoma; 1999 Jun; 18(3):263-72. PubMed ID: 10475241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoglobulins and the regulation of autoimmunity through the immune network.
    Lacroix-Desmazes S; Mouthon L; Spalter SH; Kaveri S; Kazatchkine MD
    Clin Exp Rheumatol; 1996; 14 Suppl 15():S9-15. PubMed ID: 8828942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of autoimmune responses by intravenous immunoglobulin (IVIg).
    Kaveri S; Prasad N; Vassilev T; Hurez V; Pashov A; Lacroix-Desmazes S; Kazatchkine M
    Mult Scler; 1997 Apr; 3(2):121-8. PubMed ID: 9291165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous immunoglobulins in autoimmune and inflammatory diseases: a mechanistic perspective.
    Sibéril S; Elluru S; Graff-Dubois S; Negi VS; Delignat S; Mouthon L; Lacroix-Desmazes S; Kazatchkine MD; Bayry J; Kaveri SV
    Ann N Y Acad Sci; 2007 Sep; 1110():497-506. PubMed ID: 17911465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of intravenous immunoglobulin action in the treatment of autoimmune disorders.
    Larroche C; Chanseaud Y; Garcia de la Pena-Lefebvre P; Mouthon L
    BioDrugs; 2002; 16(1):47-55. PubMed ID: 11909001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunomodulatory effects of intravenous immunoglobulins].
    Guilpain P; Chanseaud Y; Tamby MC; Larroche C; Guillevin L; Kaveri SV; Kazatchkine MD; Mouthon L
    Presse Med; 2004 Oct; 33(17):1183-94. PubMed ID: 15523290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous immunoglobulin preparations and autoimmune disorders: mechanisms of action.
    Ibáñez C; Montoro-Ronsano JB
    Curr Pharm Biotechnol; 2003 Aug; 4(4):239-47. PubMed ID: 14529426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy of specific IVIG anti-idiotypic antibodies in antiphospholipid syndrome (APS): trophoblast invasiveness and APS animal model.
    Blank M; Anafi L; Zandman-Goddard G; Krause I; Goldman S; Shalev E; Cervera R; Font J; Fridkin M; Thiesen HJ; Shoenfeld Y
    Int Immunol; 2007 Jul; 19(7):857-65. PubMed ID: 17576752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunomodulatory effects of intravenous immunoglobulins in autoimmune diseases].
    Mouthon L; Lacroix-Desmazes S; Pashov A; Kaveri SV; Kazatchkine MD
    Rev Med Interne; 1999; 20 Suppl 4():423s-430s. PubMed ID: 10522317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exogenous immunoglobulin downregulates T-cell receptor signaling and cytokine production.
    Tawfik DS; Cowan KR; Walsh AM; Hamilton WS; Goldman FD
    Pediatr Allergy Immunol; 2012 Feb; 23(1):88-95. PubMed ID: 21265884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous immunoglobulin (IVIg) in the treatment of autoimmune and inflammatory diseases.
    Ruiz de Souza V; Kaveri SV; Kazatchkine MD
    Clin Exp Rheumatol; 1993; 11 Suppl 9():S33-6. PubMed ID: 8354005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.